Pierre Gravier
Vermögen: 6 Mio $ am 31.05.2026
Vermögen: 6 Mio $ am 31.05.2026
Mr. Pierre Gravier is an Independent Director at Filana Therapeutics, Inc. and a Chief Financial Officer at PTC Therapeutics, Inc. He is on the Board of Directors at Filana Therapeutics, Inc. Mr. Gravier was previously employed as a Managing Director by Perella Weinberg Partners.
He received his graduate degree from Université de Technologie de Compiègne and a graduate degree from ESCP Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 79 243 ( 0,1 % ) | 6 Mio $ | 31.05.2026 | |
| 13.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PTC THERAPEUTICS, INC. | Finanzdirektor/CFO | 13.07.2023 |
| FILANA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.12.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| PERELLA WEINBERG PARTNERS | Corporate Officer/Principal | 01.07.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Cassava Sciences, Inc.
Cassava Sciences, Inc. BiotechnologyHealth Technology Manufactures and markets therapeutic products to detect and treat neurodegenerative diseases | Health Technology |
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Université de Technologie de Compiègne
Université de Technologie de Compiègne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perella Weinberg Partners
Perella Weinberg Partners Investment ManagersFinance Provides financial and strategic advisory services | Finance |
Escp Business School
Escp Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen